STAT Plus: ‘An unchartered situation for all of us’: From shipping containers to security concerns, a Covid-19 vaccine supply chain takes shape
For the past few months, Joachim Kuhn has scrambled to rework his factories and rapidly…
Category: Pharmalot
Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to
Talk about a rebuke. President Trump may want a Covid-19 vaccine to ship in time…
STAT Plus: A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents
A second U.S. government agency is now reviewing whether Moderna (MRNA) properly disclosed millions of…
STAT Plus: Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?
Good morning. Elizabeth Cooney here, taking the wheel from Ed Silverman today as we ponder…
STAT Plus: Pharmalittle: States asked to speed Covid-19 vaccine distribution sites; NIH panel contradicts FDA on plasma
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT Plus: Pharmalittle: U.S. won’t join WHO Covid-19 vaccine program; experts say a vaccine is possible this fall
Top of the morning to you, and a fine one it is. Despite the gray…
STAT Plus: FDA cites Mylan for ‘repeated failures’ at manufacturing plants in India
For the second time in less than a year, the Food and Drug Administration has…
STAT Plus: Congressional committee to subpoena AbbVie in drug pricing investigation
A Congressional committee plans to subpoena AbbVie (ABBV) for documents about pricing practices for two…
STAT Plus: Pharmalittle: Sanofi drug fails to tackle serious Covid-19 cases; EC agrees to fund WHO Covax program
Rise and shine, everyone, another busy day is on the way. Summertime may still be…
STAT Plus: Mylan launches a low-cost biosimilar insulin, but experts say many patients may not save on costs
Amid a national outcry over the cost of insulin, one of the largest generic companies…
.jpg)
STAT Plus: Coalition urges Justice Department to seek criminal charges against opioid executives
A coalition of advocacy groups and families is asking the Department of Justice to pursue…
STAT Plus: Pharmalittle: FDA is willing to fast-track a Covid-19 vaccine; most Americans worry politics drives vaccine approval process
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Most Americans believe the Covid-19 vaccine approval process is driven by politics, not science
Seventy-eight percent of Americans worry the Covid-19 vaccine approval process is being driven more by…
Moderna failed to disclose federal funding for vaccine patent applications, advocates say
An advocacy group has asked the Department of Defense to investigate what it called “an…
STAT Plus: Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering
Good morning, everyone. Damian Garde here, filling in for Ed Silverman in the waning hours…
STAT Plus: Employers are planning how to blunt the cost of pricey new specialty drugs
As the pharmaceutical industry develops increasingly expensive medicines – notably, those costing seven figures –…
STAT Plus: Pharmalittle: Trump launches a crusade against the FDA; Europe signs Covid-19 vaccine deal with AstraZeneca
Rise and shine, everyone, another busy day is on the way. The Pharmalot campus, for…
STAT Plus: Catalyst takes it fight over a rare disease drug to Canada, suing the country’s regulator
An unusual battle between two small companies over the market for a rare disease drug…
STAT Plus: Pharmalittle: Covid-19 vaccine makers push EU for liability protections; pharma plans counteroffer to Trump
Good morning, everyone, and how are you today? Another busy day is unfolding here on…
STAT Plus: U.S. authorities expected to file charges against Teva in generic price fixing probe
Federal prosecutors reportedly plan to charge Teva Pharmaceuticals (TEVA) of conspiring with other manufacturers of…
STAT Plus: Cardinal Health is accused of running a ‘rent-a-vet’ scheme to win government contracts
The largest association of independent nuclear pharmacies in the U.S. is accusing Cardinal Health (CAH),…
.jpg)
STAT Plus: Pharmalittle: Hahn apologizes for statistical blunder; Fauci warns of approving a Covid-19 vaccine too soon
Top of the morning to you, and a fine one it is. Blue skies and…
STAT Plus: Sun Pharma unit to pay $21 million for giving docs false instructions for an acne treatment
A unit of Sun Pharmaceuticals agreed to pay nearly $21 million to settle allegations of…
STAT Plus: Pharmacists say they tell patients about physical changes to pills, but consumers say that isn’t always the case
Most consumers say they aren’t notified of physical changes in their prescription pills, even though…
Amid pressure from scientists, NIH will study Gilead’s remdesivir-like compound against Covid-19
The National Institutes of Health plans to independently explore whether a Gilead Sciences (GILD) compound,…
STAT Plus: Pharmalittle: FDA decision to OK Covid-19 plasma prompts skepticism; will Trump fast track AstraZeneca vaccine?
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
FDA commissioner needs to push back and tell Trump the agency is not part of the ‘deep state’
The next 73 days are going to be very difficult for Stephen Hahn. As the…
STAT Plus: Pharmalittle: FDA official would resign if agency pressured to OK Covid-19 vaccine; J&J plans huge vaccine trial
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Drug makers seek to curtail discounts paid to hospitals as part of a controversial federal program
A growing number of drug makers are taking steps to curtail the discounts they offer…
STAT Plus: Boehringer to pay $379,000 to settle charges of wage discrimination against female employees
Following a review by the Department of Labor, a unit of Boehringer Ingelheim agreed to…
STAT Plus: Pharmalittle: Mail slowdown could limit access to drugs; CureVac nears a Covid-19 vaccine deal with Europe
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
STAT Plus: After FDA rejection of a key drug, is Gilead still a turnaround story?
The surprise decision by the FDA to reject a Gilead Sciences (GILD) drug for treating…
STAT Plus: Pharmalittle: FDA surprises BioMarin and Gilead by rejecting key drugs; J&J pays $6.5 billion to buy Momenta
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT Plus: Federal prosecutors allege Teva used charities to pay kickbacks to Medicare patients
Federal authorities alleged that Teva Pharmaceuticals (TEVA) donated hundreds of millions of dollars to a…
STAT Plus: FDA finalizes penalties for trial sponsors that don’t share data, but critics say the effort falls short
After a year of deliberation, the Food and Drug Administration released final guidelines for penalizing…
STAT Plus: Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: Opioid prescriptions written for Medicare Part D beneficiaries continues to drop
Amid an ongoing opioid crisis in the U.S., a new federal government report finds that…
STAT Plus: Pharmalittle: U.S. ties Covid-19 vaccine payments to milestones; Sanofi spends $3.7 billion for Principia and an MS drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Medicaid beneficiaries sue Texas health agency for restricting access to hepatitis C medicines
A group of Medicaid enrollees is accusing a Texas agency of rationing hepatitis C medicines…
STAT Plus: Pharmalittle: Governments race to acquire Covid-19 vaccines; top Russian doctor quits over vaccine ethics
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem
Amid growing concerns over antibiotic resistance, a new survey finds the vast majority of doctors…
STAT Plus: Many psoriasis patients are paying higher prices than ever at the pharmacy counter
Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing…
STAT Plus: Pharmalittle: FDA approves another Duchenne muscular dystrophy drug; European orphan drug incentives questioned
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: A long-awaited report on orphan drugs in Europe suggests incentives to pharma need change
After being kept under wraps for a year, an expansive review of European regulations designed…
STAT Plus: Pharmalittle: Moderna gets $1.5 billion U.S. contract for Covid-19 vax; state out-of-pocket caps saved residents money
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs
Amid efforts to blunt rising medicines costs, a new analysis finds three states succeeded in…
STAT Plus: Pharmalittle: Russia registers a Covid-19 vaccine amid skepticism; can monoclonal antibodies combat the coronavirus?
Rise and shine, everyone, another demanding day is on the way. We can tell if…
STAT Plus: Seizing on India’s lax standards for Covid-19 drugs, critics push for an overhaul on transparency
As Indian regulators endorse controversial treatments for Covid-19, a group of high-profile physicians and activists…
STAT Plus: Pharmalittle: One in three Americans would refuse a Covid-19 vaccine; pharma donates big-time to Congress
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Trump’s ‘Buy American’ order raises doubts; Gilead looks to boost global remdesivir output
And so, another working week will soon draw to a close. Not a moment too…